TriSalus Life Sciences, Inc. (TLSI)
NASDAQ: TLSI · Real-Time Price · USD
7.06
+0.36 (5.37%)
At close: Dec 5, 2025, 4:00 PM EST
7.20
+0.14 (1.98%)
After-hours: Dec 5, 2025, 6:57 PM EST
TriSalus Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 353 | 153 | 222 | 313 | 309 | - |
| Market Cap Growth | 180.78% | -31.30% | -29.05% | 1.52% | - | - |
| Enterprise Value | 364 | 165 | 203 | - | - | - |
| Last Close Price | 7.06 | 5.01 | 8.45 | 10.03 | 9.88 | - |
| PS Ratio | 5.80 | 5.19 | 12.01 | 25.28 | 36.75 | - |
| PB Ratio | - | -5.90 | -8.22 | -25.43 | 9.99 | - |
| EV/Sales Ratio | 9.06 | 5.60 | 10.95 | - | - | - |
| Debt / Equity Ratio | -1.28 | -0.91 | -0.06 | -0.16 | - | -0.84 |
| Asset Turnover | 1.26 | 1.21 | 0.80 | 0.41 | 0.37 | - |
| Inventory Turnover | 1.77 | 1.25 | 1.30 | 1.63 | 1.28 | - |
| Quick Ratio | 2.54 | 1.33 | 1.04 | 0.34 | 4.97 | 0.09 |
| Current Ratio | 3.06 | 2.02 | 1.42 | 0.53 | 5.51 | 0.11 |
| Return on Equity (ROE) | - | - | - | -507.96% | - | - |
| Return on Assets (ROA) | -61.10% | -93.08% | -134.61% | -76.13% | -65.35% | - |
| Return on Capital (ROIC) | -375.12% | - | - | -221.74% | -131.01% | - |
| Return on Capital Employed (ROCE) | -122.30% | -263.20% | -506.30% | 351.70% | -76.40% | 55.00% |
| Earnings Yield | -20.08% | -19.67% | -26.70% | -15.05% | -9.34% | - |
| FCF Yield | -6.28% | -26.96% | -23.01% | -10.52% | -7.71% | - |
| Buyback Yield / Dilution | -36.08% | -169.61% | -2934.71% | 96.51% | -15.52% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.